Crossmark

Identifying cardiac safety signals of disproportionate reporting for CGRP antagonists: evidence from the FDA Adverse Event Reporting System

Published Online: 2026-02-18

Authors

Xu, Shuaimin

Song, Weijuan

Wang, Yanhong

Zhao, Yang
License Information

Text and Data Mining valid from 2026-02-18

Version of Record valid from 2026-02-18
More Information

Article History

Received: 9 December 2025

Accepted: 10 February 2026

First Online: 18 February 2026

Declarations

:

: The data of this study is available publicly. Therefore, permission is not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current